Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer is a research paper published in Radiology Imaging Cancer (2023). On theSindex it has a DataRank of 0.712. It has been cited 10 times, with 10 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.352
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
National Institutes of Health
Grant: P30 CA076292
NCI NIH HHS
Grant: U54 CA193489
NCI NIH HHS
Grant: U01 CA143062
National Institutes of Health
Grant: 5U01CA143062-07
Radiomics of NSCLC
National Institutes of Health
Grant: 5U01CA200464-05
Moffitt Imaging Biomarker VAlidation Center
National Institutes of Health
Grant: 3U54CA193489-05S2
Cancer as a Complex Adaptive System
National Institutes of Health
Grant: 1R37CA229810-01A1
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology
National Institutes of Health
Grant: 5R01CA249016-03
Radiomics and Pathomics to predict upstaging of DCIS
National Institutes of Health
Grant: 3P30CA076292-24S2
Moffitt Cancer Center Support Grant
Fields of Study
MeSH Terms
Keywords